Explore prognostic biomarker of bladder cancer based on competing endogenous network. Issue 12 (23rd December 2020)

• Record Type: Journal Article
• Authors: Li, Faping; Guo, Hui; Liu, Bin; Liu, Nian; Xu, Zhixiang; Wang, Yishu; Zhou, Honglan
• Is Part Of: Bioscience reports. Volume 40:Issue 12(2020)
• Publication Date: 2020-12-23
• Subjects: Bladder cancer -- ceRNA -- lncRNA -- Overall survival -- Prognosis; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20202463
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract: Bladder cancer (BC) is the most common tumor of the urinary tract. Increasing evidence showed that long non-coding RNA (lncRNA) is a critical regulator in cancer development and progression. However, the functions of lncRNAs in the development of BC remain mostly undefined. In the present study, based on RNA sequence profiles from The Cancer Genome Atlas database, we identified 723 lncRNAs, 157 miRNAs, and 1816 mRNAs aberrantly expressed in BC tissues. A competing endogenous RNA network, including 49 lncRNAs, 17 miRNAs, and 36 mRNAs, was then established. The functional enrichment analyses showed that the mRNAs in the ceRNA network mainly participated in 'regulation of transcription' and 'pathways in cancer'. Moreover, the Cox regression analyses demonstrated that three lncRNAs (AC112721.1, TMPRSS11GP, and ADAMTS9-AS1) could serve as independent risk factors. We established a risk prediction model with these lncRNAs. Kaplan–Meier curve analysis showed that high-risk patients' prognosis was lower than that of low-risk patients ( P =0.001). The present study provides novel insights into the lncRNA-mediated ceRNA network and the potential of lncRNAs to be candidate prognostic biomarkers in BC, which could help better understand the pathological changes and pathogenesis of BC and be useful for clinical studies in the future.